Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
about
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.Educational paper. The development of new therapies for pediatric oncology.Stem cells: a model for screening, discovery and development of drugs.Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse.
P2860
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@en
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@nl
type
label
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@en
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@nl
prefLabel
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@en
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@nl
P1433
P1476
Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date.
@en
P2093
Franklin O Smith
Patrick Brown
P356
10.2165/00148581-200810020-00003
P577
2008-01-01T00:00:00Z
P6179
1029840731